CTLA4 and metastatic melanoma: While we were unable to appreciate significant changes in phenotype or bioenergetics, we do demonstrate that TILs derived from patients with CPI-resistant metastatic melanoma retain a type of plasticity that can be influenced by disrupting PD-1 and CTLA-4 interactions.